John Botson, RPh
Rheumatology · Anchorage, AKNPI 1881700334
Payments from drug & device makers
Across 1,298 payments — averaging $3352.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4.1M
- AbbVie$78K
- Novartis$68K
- ANI Pharmaceuticals, Inc.$34K
- Lilly USA, LLC$24K
- Bristol Myers Squibb$16K
- plus $34K from 18 others
Across 1 payment — averaging $4864.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$5K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 757 | $4,095,942 |
| AbbVie | 138 | $78,331 |
| Novartis | 136 | $68,217 |
| ANI Pharmaceuticals, Inc. | 43 | $34,024 |
| Lilly USA, LLC | 50 | $24,363 |
| Bristol Myers Squibb | 21 | $16,381 |
| Sobi, Inc | 12 | $8,905 |
| Eli Lilly | 3 | $7,238 |
| Pfizer | 17 | $6,691 |
| Aurinia Pharma U.S., Inc. | 6 | $5,725 |
| AstraZeneca(2 entities) | 27 | $2,769 |
| Johnson & Johnson | 29 | $979 |
| Radius Health, Inc. | 16 | $764 |
| GSK | 15 | $475 |
| UCB, Inc. | 9 | $256 |
| Regeneron Healthcare Solutions, Inc. | 5 | $209 |
| Mallinckrodt Hospital Products Inc. | 4 | $181 |
| Sanofi | 3 | $73 |
| Boehringer Ingelheim | 2 | $37 |
| Genentech USA, Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Welch Allyn | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
How this compares
Too few rheumatology providers in Alaskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Anchorage
- Yael KlionskyAnchorage$218K
- Cristina CopusAnchorage$3K
- Summer Engler JagerAnchorage$3K
- Ryan RagleAnchorage$3K
- Claribel TanAnchorage$713
- Javaneh LyonsAnchorage$102
- James HaigneyAnchorage$78
- Vivek MehtaAnchorage$33
- Elizabeth FerucciAnchorage$0
- Raymond WilsonFairbanks$274
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.